Search results
Microvascular Complications and Outcome after Drug-eluting Stent Implantation in Diabetic Patients
Author(s):
Carlo Briguori
,
Antonio Colombo
Added:
3 years ago
Article
Author(s):
Takashi Unoki
,
Shuichi Ura
,
Daisuke Takagi
,
et al
Added:
3 years ago
Topic: Atherosclerosis (Clinical), Cardiac Catheterisation
The lymphatic system has been suggested to play an important role in cholesterol metabolism and cardiovascular disease. Vascular endothelial growth factor-C (VEGF-C) plays a key role in lymphangiogenesis. Recently, we demonstrated that VEGF-C is closely associated with dyslipidemia and atherosclerosis. However, the relationship between…
View more
Author(s):
David Leistner
Added:
1 year ago
In this short interview from EuroPCR 22, Prof David Leistner (Charité Universitätsmedizin, DE) joins us on-site to outline the key findings of the CRUZ-HBR registry. This was a real-world study to confirm the outcomes of the Supraflex™ Cruz stent (SMT Ltd) in all-comer patients, where half of the cohort were at high bleeding risk.
Results suggest that the Supraflex™ Cruz stent had a favourable…
View more
Author(s):
Paul A Gurbel
,
David Kandzari
Added:
3 years ago
The rare but catastrophic occurrence of stent thrombosis, in particular 'late' stent thrombosis, in association with deployment of drug-eluting stents has focused attention on the adequacy of the current dual anti-platelet regimen of aspirin and clopidogrel. Stent thrombosis is due to multiple factors. These include, specific stent features (delayed healing or polymer hypersensitivity),…
View more
Rayyan Hemetsberger
Job title: Interventional Cardiologist
Author
Author(s):
Tamara García Camarero
,
José M de la Torre Hernández
Added:
3 years ago
The use of dual antiplatelet therapy (DAPT) after stent implantation in a percutaneous coronary intervention (PCI) is the standard treatment. The first randomised controlled trial (RCT) to establish the superiority of DAPT versus oral anticoagulant treatment among patients undergoing PCI was the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial, published in 1996.1 Since then, more…
View more
Featuring: Dr Patrick Serruys
Author(s):
Patrick W Serruys
Added:
3 years ago
Article
Author(s):
Gregg Stone
Added:
7 months ago
ESC 2023 — Dr Gregg Stone (Icahn School of Medicine at Mount Sinai, US) shares the findings from a real-time updated network meta-analysis comparing OCT, IVUS and Angiography guidance in percutaneous coronary intervention (PCI) procedures.
The OCTOBER and ILUMIEN IV randomised trials both studied OCT-guided versus angiography-guided PCI. This analysis compared the overall effects of…
View more
Paolo Canova
Author
Author(s):
Dae-Hyun Lee
,
José M de la Torre Hernández
Added:
3 years ago
When Andreas Grüntzig introduced balloon coronary angioplasty in 1977 it represented the first alternative to coronary artery bypass graft surgery. However, balloon dilatation had inherent limitations – including elastic recoil and vessel closure in the acute phase, as well as negative remodelling and restenosis in the late phase – which limited its applicability and further expansion. In the…
View more